Facebook-f Twitter Linkedin-in
August 19, 2025
  1. Home
  2. Buyout

Category: SR One

Buyout GlaxoSmithKline spinout SR One strikes $500m hard cap for debut independent fundraise

GlaxoSmithKline spinout SR One strikes $500m hard cap for debut independent fundraise

Transatlantic biotech investor SR One has raised its first fund in the wake of spinning out from pharmaceutical giant GlaxoSmithKline.

We use cookies to offer you a better browsing experience. If you continue to use this site, you consent to our use of cookies.
I Accept Cookies
We use cookies to offer you a better browsing experience. If you continue to use this site, you consent to our use of cookies.
I Accept Cookies